• Compare them with Saudi Arabian healthcare environments; attempting to find the main differences between those health entities, in-order to improve the local healthcare facilities. Research Questions • Q. What are people writing about patient experience when they are talking about it? • Q. What are the factors / aspects that identify, define and improve patient (and family) experience in healthcare environment?
1) This case provides background on DTC marketing for prescription drugs and also suggests that the use of this type of marketing is somewhat controversial. What ethical issues can you identify that might be of concern to patients, healthcare professionals, and pharmaceutical companies with regard to DTC marketing? Be specific. The type of marketing used by pharmaceutical companies is a pull marketing strategy. In the past, they had to rely on their channel members which are healthcare professionals to reach consumers.
Discussion Points: 1. Learning’s from the past: a. The Hopkins incident uncovered some serious problems with the investigator and the IRB committee. As a sponsor’s representative you should make sure that your investigator submits complete and detailed study information to the IRB necessary for approval. If your company is using a previously approved drug for a new route of administration you should consult with the FDA to see if an IND needs to be submitted prior to the start of a clinical trial.
Overall, medical practice is performed when physicians identify health concerns, including diseases, mental disorders, and physical injuries, and provide a treatment for their patients in order to properly cure them of their maladies. The appropriate basis for medical practice is a combination of physicians’ knowledge acquired from scientific research and education, and ethical considerations regarding the wellbeing of patients. Additionally, if no scientific support is available, patients must rely on intuition and experience in order to make a proper diagnosis. On the whole, science plays a major role in the realm of medicine, as it is the foundation for the creation of new treatments and education. Science is defined as “…research firmly based upon one or more past scientific achievements, achievements that some particular scientific community acknowledges for a time as supplying the foundation for its further practice” (Kuhn 70).
The pharmacist should carry out medicines use reviews for patients with RA, particularly those taking NSAIDs and other high risk drugs to ensure management of the condition. The pharmacist will ask questions regarding symptoms, side effects and how they are getting on with their treatment in order to check management of the condition. They should also be asked about any other OTC/herbal medicines they are taking. Patients should be asked about any symptoms they are experiencing whilst using treatment prescribed. Therapeutic benefits of treatment would be preventing and controlling symptoms and pain as well as improving functional disability.
Psychopharmacology This paper will examine the complicated roles a counselor has related to the use of prescribed medication in treating mental health issues. The first section will explore the boundaries and ethical implications for a counselor surrounding the recommendation and prescription of psychotropic medication. The next section will include the counselor’s role in client education about medication. The third section will relate to the details of client referral when medication is warranted. Boundaries and Ethical Implications As a result of research and advancements in biomedical science, psychotropic medications have become a primary tool in the holistic treatment of mental health concerns (Kaut & Dickinson, 2007).
I would then sit down with the staff member who was drug diverting or tested positive for the drug, to discuss consequences. I would also sit down with my staff as a whole about how to handle this type of situation in the future, the importance of reporting, the problems of using drugs and drug diversion, and debrief the staff about necessary information they needed to know about this incidence. 2. Review a current facility’s policy of suspected drug diversion. Summarize the process. I reviewed Vanderbilt University Medical Centers Substance Abuse Policy that highlights protocol and drug diversion (Vanderbilt University and Medical Center Human Resources Policies and Procedures, 2012).
What would be the benefits and drawbacks for Bronwyn, whose story was featured in Unit 2, of being assessed as having a psychiatric disorder? To be assessed as having a psychiatric disorder requires medical diagnosis, either from a doctor or a mental health practitioner. A treatment plan will be offered if a diagnosis is made that may include medication and a care plan. Bronwyn is an example of someone who is not classified with a psychiatric disorder, yet is questioning her mental health as life has become unmanageable and overwhelming (The Open University, 2008). The K225 Course Model examines the external influences of the service user and determines whether they have contributed to the mental distress being experienced (The Open University, 2008b, pp.26-27).
74-91). Obtaining an extensive biopsychosocial history is necessary in properly identifying and subsequently treating the two disorders. Once treatment begins, therapists must be aware of the hazardous side effects of medications to assist their clients and physicians in treatment of either disorder. It is this author’s hope that the information presented not only helps distinguish the pharmacotherapy of both MDD and BPAD, but also provided cautions to other mental health professionals for side effect monitoring. Works Cited Kelsey, J.E., Newport, D. J., & Nemeroff, C.B.
The contracts may update professional services as it relates to a change in populations. The inclusion of a sub-acute unit that requires more advanced equipment, multiple medication changes, and an advanced emergency kit represents an update to professional services. 4 The role of the consultant pharmacist involves overseeing pharmaceutical services as well as evaluating and monitoring drug therapy of residents (Brown, 1988). The consultant pharmacist should have a written agreement or contract with the facility that outlines responsibilities and scope of service. The pharmacist coordinates pharmaceutical services in the pharmacy contract.